GlassScriptPhysician profile
Julie E Castner
NPI 1508357435
$8,297.34
in general payments reported to CMS, 2019-2025
40 companies · $2,032 in 2025
The $2,032 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,421 · 2023: $2,575 · 2024: $2,269 · 2025: $2,032.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,876.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,876.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,173.88 | 2022-2025 | |
| Glaxosmithkline, LLC. | $996.87 | 2022-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Novo Nordisk INC | $798.66 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $748.61 | 2022-2025 | Breztri, Farxiga, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $741.84 | 2022-2025 | Jardiance, Spiriva Respimat |
| Pfizer INC. | $669.70 | 2023-2025 | |
| Lilly USA, LLC | $525.46 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $362.90 | 2022-2025 | Evenity, Repatha, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $254.59 | 2022-2023 | |
| Astellas Pharma US INC | $190.14 | 2022-2025 | Veozah, Myrbetriq |
| Exact Sciences Corporation | $161.27 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Collegium Pharmaceutical, INC. | $153.34 | 2023-2024 | Xtampza |
| Phathom Pharmaceuticals, INC. | $145.09 | 2024-2025 | Voquezna |
| Biohaven Pharmaceutical Holding Company LTD. | $143.29 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $113.53 | 2022-2023 | Xifaxan |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $110.43 | 2022-2025 | Gardasil 9, Vaxneuvance, Gardasil |
| Boston Scientific Corporation | $108.64 | 2023-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Janssen Pharmaceuticals, INC | $88.20 | 2024-2025 | Spravato |
| Alnylam Pharmaceuticals INC. | $79.69 | 2025 | Amvuttra |
| Kowa Pharmaceuticals America, INC. | $77.03 | 2022-2023 | Livalo, Seglentis |
| Novartis Pharmaceuticals Corporation | $68.69 | 2022-2023 | |
| Dexcom, INC. | $52.14 | 2023-2024 | Dexcom G6 Transmitter |
| Takeda Pharmaceuticals U.S.A., INC. | $49.32 | 2022 | |
| Ibsa Pharma INC. | $47.37 | 2022 | |
| Cranial Technologies, INC | $47.32 | 2023-2025 | Doc Band |
| Hologic Sales and Service, LLC | $46.02 | 2023-2024 | Aptima |
| Alexion Pharmaceuticals, INC. | $43.18 | 2023 | Strensiq |
| Seqirus USA INC | $40.67 | 2023-2024 | Fluad, Flucelvax, Fluad Quadrivalent |
| Eisai INC. | $36.55 | 2025 | |
| Qiagen, LLC | $29.42 | 2023 | |
| Verity Pharmaceuticals INC. | $28.23 | 2025 | Tlando |
| Daiichi Sankyo INC. | $25.31 | 2025 | Injectafer |
| Medtronic, INC. | $21.21 | 2022 | |
| Sanofi-Aventis U.S. LLC | $21.08 | 2023 | |
| Xeris Pharmaceuticals, INC. | $20.95 | 2023 | Keveyis |
| Abbott Laboratories | $17.31 | 2025 | Id Now Instrument |
| Currax Pharmaceuticals LLC | $16.41 | 2025 | Contrave |
| Idorsia Pharmaceuticals US INC | $15.69 | 2023 | Quviviq |
| Therapeuticsmd, INC. | $14.12 | 2022 | |
| Amarin Pharma, INC. | $13.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Castner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.